Sunshine Biopharma Inc. is a Colorado corporation with head offices in Montreal, Canada. The Company is fully reporting in the U.S. (www.SEC.gov) and Canada (www.SEDAR.com). Sunshine Biopharma’s Common Shares are traded on the OTCQB market under the ticker symbol SBFM. The Company’s business activities are focused on the research, development and commercialization of drugs for the treatment of cancer. Our initial drug candidate, Adva-27a, is a small molecule that has proven effective against different types of multidrug resistant cancer cell lines including breast cancer (MCF-7/MDR), small-cell lung cancer (H69AR), uterine carcinoma (MES-SA/Dx5) and pancreatic cancer (Panc-1).